TrialWorld journal of gastroenterology2013

A phase II study of paclitaxel and nedaplatin as front-line chemotherapy in Chinese patients with metastatic esophageal squamous cell carcinoma.

Yi-Fu He et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.